1Witter R L. Control strategies for Matek's disease: A perspective for the future [J]. Poultry Science, 1998, 77: 1197-1203.
2Nazerian K, Witter R L, Lee L E Pretection and synergism by recombinant fowlpox vaccines expressing genes from Marek' s disease virus[J]. Avian Dis, 1996, 40(2): 368-375.
3Ross L J N. Nucleotide Sequence and Characterization of the Marek's Disease Virus Homologue of Glycoprotein B of Herpes Simplex Virus[J]. J gen Virol, 1989, 70:1789-1804.
4Yoshida S, Lee L F, Yanagida N, Nazerian K. The Glycoprotein B Genes of Marek' s Disease Virus Serotypes 2 and 3: Identification and Expression by Recombinant Fowlpox Viruses[J]. Virology,1994, 200:484-493.
5Ross L J N. Recombinant vaccines against Marek's disease[J]. Avian Pathology, 1998, 27: 65-73.
6Mcclements W L, Armstrong M E, Keys R D, et al. Immunization with DNA vaccines encoding glycoprotein B, alone or in combination,induces protective immtmity in animal models of herpes simplex virus-2 disease. Proceedings of the National Academy of Sciences,USA[J]. 1996, 93: 11414-11420.
7Kuklin N, Dahesia M, Karem K, et al. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization [J]. J Virol, 1997, 71: 3138-3145.
8Nazerian K, Witter RL, Lee LF et al. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek′s disease virus. Avian Dis,1996,40(2):368-376.
9Heine HG, Foord AJ, Young PL et al.Recombinant fowlpox virus vaccines against Australian virulent Marek′s disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens. Virus Res ,1997,50(1) :23-33.
10Niikura M, Matsuura Y, Endoh D et al. Expression of the Marek′s disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV. J Virol, 1992, 66(5):2631-2638.
